Column Capital Advisors’s Exelixis EXEL Stock Holding History

Column Capital Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40	Closed	-$764	–	810
2023 Q2	$764	Hold	40	–	–	﹤0.01%	763
2023 Q1	$776	Hold	40	–	–	﹤0.01%	782
2022 Q4	$642	Buy	+40	New	+$652	﹤0.01%	786
2021 Q4	–	Sell	-67	Closed	-$1K	–	795
2021 Q3	$1K	Hold	67	–	–	﹤0.01%	674
2021 Q2	$1K	Hold	67	–	–	﹤0.01%	668
2021 Q1	$2K	Hold	67	–	–	﹤0.01%	611
2020 Q4	$1K	Hold	67	–	–	﹤0.01%	644
2020 Q3	$2K	Hold	67	–	–	﹤0.01%	590
2020 Q2	$1K	Hold	67	–	–	﹤0.01%	733
2020 Q1	$1K	Sell	67 -2	-3%	-$37	﹤0.01%	616
2019 Q4	$1K	Buy	+69	New	+$1.17K	﹤0.01%	653

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Column Capital Advisors's EXEL Position: Q3 2023 in Review

Column Capital Advisors sold out of Exelixis (EXEL) in Q3 2023, closing a stake of 40 shares — an estimated $764 sold.

Column Capital Advisors first reported a position in EXEL in Q4 2019 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 399 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

Column Capital Advisors reported no remaining Exelixis position as of Q3 2023 after selling out during the quarter.
Column Capital Advisors sold 40 Exelixis shares in Q3 2023, an estimated $764.
Column Capital Advisors first reported a position in Exelixis in Q4 2019 and held it in 11 quarters.
Column Capital Advisors's Exelixis position peaked at $2K in Q1 2021.
399 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.